Apollon Wealth Management »

Ptc Therapeutics I shares owned by Apollon Wealth Management

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Apollon Wealth Management from 13F filings

Historical chart of Apollon Wealth Management investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Apollon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Apollon Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $487k 18k 27.56
2023-09-30 $396k 18k 22.41
2023-06-30 $719k 18k 40.67

More positions owned by Apollon Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
NVIDIA Corporation (NVDA)
Vanguard Specialized Funds Div App Etf (VIG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Apollon Wealth Management

Top funds holding Ptc Therapeutics I

Wellington Management Company
Vanguard Group
Cowen And Company
Henderson Group
Franklin Resources
D. E. Shaw & Co
Jacobs Levy Equity Management
Blackstone Group
T. Rowe Price Associates
Tang Capital Management
Voloridge Investment Management
Jane Street
Jpmorgan Chase & Co
Charles Schwab Investment Management
Norges Bank Investment Management

View all funds holding Ptc Therapeutics I